These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7841135)

  • 1. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures.
    Yao JK; van Kammen DP; Gurklis J
    Schizophr Res; 1994 Oct; 13(3):227-32. PubMed ID: 7841135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition.
    Yao JK; van Kammen DP; Welker JA
    Schizophr Res; 1994 Oct; 13(3):217-26. PubMed ID: 7841134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity.
    Yao JK; van Kammen DP
    Schizophr Res; 1994 Feb; 11(3):209-16. PubMed ID: 8193060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia.
    Yao JK; Sistilli CG; van Kammen DP
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):429-36. PubMed ID: 14623497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.
    Glen AI; Glen EM; Horrobin DF; Vaddadi KS; Spellman M; Morse-Fisher N; Ellis K; Skinner FS
    Schizophr Res; 1994 Apr; 12(1):53-61. PubMed ID: 8018585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBC and plasma choline in neuroleptic-treated schizophrenic patients.
    Lawson WB; Jeste DV; Hanin I; Kopp U; Wyatt RJ
    Psychiatry Res; 1989 Jul; 29(1):45-53. PubMed ID: 2570429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary supplementation of saturated fatty acids and of n-6 or n-3 polyunsaturated fatty acids on plasma and red blood cell membrane phospholipids and deformability in weanling guinea pigs.
    Pöschl JM; Paul K; Leichsenring M; Han SR; Pfisterer M; Bremer HJ; Linderkamp O
    Lipids; 1999 May; 34(5):467-73. PubMed ID: 10380118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients.
    Peet M; Laugharne J; Rangarajan N; Horrobin D; Reynolds G
    J Psychiatr Res; 1995; 29(3):227-32. PubMed ID: 7473298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pupillary constriction during haloperidol treatment as a predictor of relapse following drug withdrawal in schizophrenic patients.
    Steinhauer SR; van Kammen DP; Colbert K; Peters JL; Zubin J
    Psychiatry Res; 1992 Sep; 43(3):287-98. PubMed ID: 1438625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
    Assies J; Lieverse R; Vreken P; Wanders RJ; Dingemans PM; Linszen DH
    Biol Psychiatry; 2001 Mar; 49(6):510-22. PubMed ID: 11257236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormality in membrane fatty acid compositions of cells measured on erythrocyte in alcoholic liver disease.
    Shiraishi K; Matsuzaki S; Itakura M; Ishida H
    Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):56A-59A. PubMed ID: 8659691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid abnormalities in plasma and red cell membranes of chronic alcoholics.
    Clemens MR; Schied HW; Daiss W; Waller HD
    Klin Wochenschr; 1986 Feb; 64(4):181-5. PubMed ID: 3959497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.
    Forman SD; Bissette G; Yao J; Nemeroff CB; van Kammen DP
    Schizophr Res; 1994 Apr; 12(1):43-51. PubMed ID: 8018584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients.
    Peet M; Shah S; Selvam K; Ramchand CN
    World J Biol Psychiatry; 2004 Apr; 5(2):92-9. PubMed ID: 15179668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hostility of drug-free patients with schizophrenia and n-3 polyunsaturated fatty acid levels in red blood cells.
    Watari M; Hamazaki K; Hirata T; Hamazaki T; Okubo Y
    Psychiatry Res; 2010 May; 177(1-2):22-6. PubMed ID: 20227767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte membrane phospholipids in psychotic patients.
    Keshavan MS; Mallinger AG; Pettegrew JW; Dippold C
    Psychiatry Res; 1993 Oct; 49(1):89-95. PubMed ID: 8140184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
    van Kammen DP; Peters J; van Kammen WB; Nugent A; Goetz KL; Yao J; Linnoila M
    Biol Psychiatry; 1989 Jun; 26(2):176-88. PubMed ID: 2472177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty fish-induced changes in membrane lipid composition and viscosity of human erythrocyte suspensions.
    Popp-Snijders C; Schouten JA; van der Meer J; van der Veen EA
    Scand J Clin Lab Invest; 1986 May; 46(3):253-8. PubMed ID: 3715378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients.
    Vaddadi KS; Gilleard CJ; Mindham RH; Butler R
    Psychopharmacology (Berl); 1986; 88(3):362-7. PubMed ID: 2870533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.